| |
Treating
opiate addiction, Part II:
Alternatives to maintenance
(This article was first printed in the January
2005 issue of the Harvard Mental Health
Letter. For more information or to order,
please go to www.health.harvard.edu/mental.)
Naltrexone
A different kind of drug treatment for opiate
addicts is the long-acting opiate antagonist
naltrexone, taken three times a week after detoxification.
It blocks opiate receptors, neutralizes or reverses
the effects of opiates, and triggers a withdrawal
reaction in anyone who is physically dependent
on opiates. An addict who takes naltrexone faithfully
will never relapse, but most addicts simply stop
using it, or refuse to take it in the first place.
An authoritative review of controlled studies
concludes that at present there is not enough
evidence to justify this use of naltrexone. But
even if most addicts will not continue to take
the drug, some may — especially physicians
and other middle-class patients who are highly
motivated to get free of the opiate because they
have so much to lose from a persistent addiction.
Drug chemists are now trying to make it more
difficult to discontinue naltrexone by providing
it in the form of an injection under the skin
for slow release over a period of several weeks.
As of 2005, this product has not yet received
FDA approval.
Behavioral treatment
Behavioral therapists regard opiate addiction
as the effect of learned associations and patterns
of reward and punishment. Patients learn to identify
and remember moods, thoughts, and situations
that tempt them to use opiates. The therapist
helps them avoid these temptations, consider
the consequences of relapse, and find other ways
to achieve a feeling of pleasure or accomplishment.
Training in stress management, relaxation, and
general problem-solving may also help. Cognitive
therapists try to help addicts recognize and
dismiss self-defeating attitudes that make life
seem unbearable without the drug.
A special form of behavioral treatment is contingency
management. Addicts are given vouchers they can
redeem for goods and services if their urine
remains free of drugs. Patients may also take
naltrexone to make casual relapse more difficult.
Although contingency management has been found
effective in some studies, critics say that it
costs too much and is too difficult to put into
practice.
Psychotherapy
Individual psychotherapy is never recommended
as the main treatment for opiate addiction; it
rarely succeeds because addicts are reluctant
participants at best. Addiction must be addressed
directly rather than treated as the symptom of
some other emotional problem. But opiate addicts
often have psychiatric symptoms and psychiatric
disorders, and some of these dually diagnosed
patients can make good use of psychotherapy — psychodynamic,
interpersonal, or supportive — as long
as the addiction is treated at the same time.
Group therapy
Group treatment is often preferred for addicts.
It makes use of the need to belong and the healing
power of human connections. The group helps addicts
feel less isolated and ashamed and allows them
to help themselves by helping others. Groups
can provide both emotional support and confrontation,
along with information and understanding.
Residential treatment
Some withdrawing addicts are treated in residential
chemical dependency programs that provide individual
and group therapy, 12-step support groups, and
other services, usually for a month to three
months. Other addicts join therapeutic communities
in which they are expected to remain for six
months to two years, participating in group meetings
while following strict rules that allow them
gradually to acquire more personal freedom as
they show their capacity to assume responsibility
and avoid drugs. Middle-class addicts are more
likely to enroll in chemical dependency programs;
residential therapeutic communities usually attract
street heroin addicts who lack jobs, stable marriages,
and sometimes even homes.
Support groups
Mutual aid groups for opiate addicts follow
the same lines as those established earlier for
alcoholics. The best known, Narcotics Anonymous,
uses the 12-step procedures developed by Alcoholics
Anonymous. Other self-help groups, such as Smart
Recovery, rely less on appeals to a higher power
and more on cognitive and behavioral principles.
Family counseling
Where possible, it is important to enlist the
addict’s family. Relatives can be coached
on how to confront the patient or taught how
to facilitate cognitive and behavioral therapy.
In a variant called network therapy, friends
and relatives become part of the therapeutic
team, meeting to discuss what to do in relapses
and other emergencies. Relatives can also join
family support groups like Narc-Anon.
Stages of change
In any kind of treatment for addiction, it is
important to understand what kind of change is
possible at a given time for a given person.
Researchers have discovered five stages through
which most people go when they decide to change
their lives: precontemplation, preparation, contemplation,
action, and maintenance.
At the precontemplation stage, they are not
yet persuaded that they have a problem; in addicts,
this stage has previously been called denial.
At the contemplation stage, they have begun to
acknowledge the need for change but have not
yet made a commitment. The preparation stage
involves plans for action, and maintenance means
avoiding relapse.
Addicts rarely pass through these stages smoothly
the first time. When they stall or regress, they
must be urged not to become demoralized and give
up. Some professionals who work with addicts
believe that the choice of treatment should depend
on which stage they have reached; for example,
psychotherapy may help at the precontemplation
and contemplation stages, while cognitive and
behavioral therapies may be more appropriate
for the action and maintenance stages.
State of the art and practice
Methadone maintenance remains the most successful
treatment for opiate addiction. Other approaches
have a mixed record. But even if no two addicts
respond to the same approach, treatment does
work for many, and others eventually get free
of the drug on their own.
But anger and resentment alternate with sympathy
and concern in public and professional attitudes
toward opiate addiction. Physicians often regard
addicts as a nuisance and are reluctant to treat
them. The public has doubts about devoting medical
resources to people who seem to have brought
their troubles on themselves and who may seem
both demanding and ungrateful when they are offered
help. Opiate maintenance is still politically
and socially, although not medically, controversial;
some still regard it as official indulgence of
a criminal vice. Methadone clinics are strictly
regulated, sometimes to the extent of setting
the maximum dose and length of treatment. Even
so, the clinics are unpopular with neighbors
and waiting lists are long. Buprenorphine maintenance
is an exciting new development because it lacks
some of these drawbacks of methadone. For further
improvement, we will need not only more effective
medications and therapeutic techniques, but also
a better public understanding of the disorder
of opiate addiction.
Resources
American Society of Addiction Medicine
301-656-3920
www.asam.org
Buprenorphine Information Center
866-287-2728 (toll free)
www.buprenorphine.samhsa.gov
Narcotics Anonymous World Services
818-773-9999
www.na.org
National Institute on Drug Abuse
301-443-1124
www.drugabuse.gov
Smart Recovery
866-951-5357 (toll free)
www.smartrecovery.org
Substance Abuse and Mental Health Services Administration
(SAMHSA)
800-662-4357 (toll free)
http://findtreatment.samhsa.gov
References
DiClemente C, et al. “Readiness
and Stages of Change in Addiction Treatment,” American
Journal on Addictions (March–April
2004): Vol. 13, No. 2, pp. 103 – 19.
Fudala PJ, et al. “Office-Based
Treatment of Opiate Addiction with a Sublingual-Tablet
Formulation of Buprenorphine and Naloxone,” New
England Journal of Medicine (Sept.
4, 2003): Vol. 349, No. 10, pp. 949 – 958.
Gabbard GO, ed. Treatments of Psychiatric
Disorders, Second Edition. American
Psychiatric Press, 1995.
Kleber HD. “Pharmacologic Treatments
for Heroin and Cocaine Dependence,” American
Journal on Addictions (2003): Vol.
12, Suppl. 2, pp. S5 – S18.
Lowinson JH, et al. eds. Substance
Abuse: A Comprehensive Textbook, Third
Edition. Williams and Wilkins, 1997.
van den Brink W, et al. “Management
of Opioid Dependence,” Current
Opinion in Psychiatry (2003): Vol.
16, pp. 297 – 304. |
(This article was first printed in the January
2005 issue of the Harvard Mental Health
Letter. For more information or to order,
please go to www.health.harvard.edu/mental.)
|
|